Menu
Search
Home > Courses > 2018 Conference Updates from ID Week in San Francisco and IAS in Amsterdam

2018 Conference Updates from ID Week in San Francisco and IAS in Amsterdam

2018 Conference Updates from ID Week in San Francisco and IAS in Amsterdam
Play
Sorry, this learning module is not available for mobile devices.
Original Release Date: 11/13/2018
Termination Date: 11/12/2021
Review Date: 3/11/2019
Presenter
  • W. David Hardy, MD
    Adjunct Professor
    Johns Hopkins University of Medicine
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Better appreciate new data regarding diagnosis and treatment of coinfections seen in PLWH.
  2. Understand new developments regarding diagnosis, prevention and treatment of comorbidities seen in PLWH.
  3. Be aware of how these coinfections and comorbidities impact mortality and morbidity of PLWH.
Presenter Bio
W. David Hardy, MD
Dr. Hardy received his medical degree from Baylor College of Medicine, Houston, TX and completed his residency in internal medicine at Harbor-UCLA Medical Center in Torrance, California. Early in the AIDS epidemic, he completed a clinical fellowship in infectious diseases/immunology and clinical research at the UCLA School of Medicine under the direction of Dr Michael Gottlieb, the physician who recognized and reported the first cases of AIDS. Later he also completed a laboratory fellowship in molecular retrovirology at the David Geffen School of Medicine at UCLA. Dr. Hardy has cared for persons with HIV infection since 1982 and conducted research on HIV and related diseases since 1984. Initially, he focused on treatment and prevention of opportunistic infections and currently on antiretroviral agents, immunotherapies and hepatitis treatments as well as retroviral vector research and gene therapy. Dr Hardy currently serves as Chair-Elect of the Board of Directors of the HIV Medicine Association (HIVMA) and will advance to Chair in 2018. Dr. Hardy also serves as Chair of the Education Committee of the American Academy of HIV Medicine (AAHIVM). He served as editor-in-chief of AAHIVM’s comprehensive clinical textbook, Fundamentals of HIV Medicine for the HIV Specialist published in 2007, 2008, 2012, 2017 and 2019.
Continuing Education Credit

This CME activity was approved for AMA PRA Category 1 Credit on November 13, 2018 and will terminate November 12, 2021.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
  • You must achieve at least 70% correct to receive your CME certificate.
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.

 Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.  

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
  • Dr. W. David Hardy (Presenter) has had the following personal financial relationships in the past 12 months with manufacturers of the products or services that may be presented in this CME activity: Research grants from Gilead, Janssen, Merck, and ViiV; Advisory board member to Gilead, Merck, and ViiV. Dr. Hardy submitted his slides in advance for adequate peer review, and will support his presentation and clinical recommendations with the best available evidence from the medical literature.

Financial Support

This meeting of the Physicians’ Research Network (PRN) and enduring material were funded in part by educational grants from: Gilead Sciences, Janssen Therapeutics (a division of Janssen Products, LP), Merck & Co., and ViiV Healthcare.

Details: 

  • This online video and post-activity evaluation are one hour in length. 
  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
PRN Learning Modules